logo_image
Headline: Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
Location: Ann Arbor, MI, US
Post Date: Feb 21, 2020 4:38 PM
TAG ID: pznews112071
DocID: 202002217818781-en.xml
Word Count: approx. 1918 words
 
Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
 
Please login to download this Story
 

logo_image
Headline: Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
Location: Ann Arbor, MI, US
Post Date: Feb 21, 2020 4:38 PM
TAG ID: pznews112071
DocID: 202002217818781-en.xml
Word Count: approx. 1918 words
 
Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
 
Please login to download this Story